Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Prior Authorization Is Under Review

Philip Seo, MD, MHS  |  February 10, 2022

I just couldn’t believe it. Like all of you, I receive many requests to see patients urgently. And like all of you, I can’t possibly accommodate all of those requests. So I triage: I look through the referrals and try to differentiate patients who want to be seen from those who need to be seen….

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:prior authorization

Clinical Insights into Gout Management: Q&A with Dr. Tuhina Neogi

Mary Choy, PharmD, BCGP, FASHP  |  February 9, 2022

Gout affects more than 9.2 million adults in the U.S. and is the most common form of inflammatory arthritis. This condition and its complications are painful and potentially disabling with varying risk factors. It is characterized by symptoms that are usually sudden, with intense episodes of painful swelling in one or more joints, most often…

Filed under:ACR ConvergenceClinical Criteria/GuidelinesConditionsDrug UpdatesGout and Crystalline ArthritisMeeting Reports Tagged with:Dr. Tuhina NeogiGoutGout Resource Center

An Oral Targeted Therapy: RheumMadness 2022 Pim Kinases Scouting Report

Residents from the RheumMadness Leadership Team: Michael Macklin, MD, PharmD; Ben Kellogg, MD; Lauren He, MD; & David Leverenz, MD  |  February 8, 2022

According to research, Pim kinases contribute to the pathogenesis of rheumatoid arthritis (RA) and may have the therapeutic potential for inhibition in patients with RA.

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:cellsPim kinaseRheumatoid Arthritis (RA)RheumMadness

‘Nothing but NET[osis]’: RheumMadness 2022 Anti-NET Antibodies Scouting Report

The UNC Rheumatology Fellowship Program: Leah Bettner, MD; Shruti Chandramouli, MD; Christopher Overton, MD; Astia Allenzara, MD; Michael Cunningham, MD; & Luis Palomino, MD  |  February 8, 2022

Neutrophil extracellular traps (NETs) contribute to the pathogenesis of multiple autoimmune diseases. And research has shown that patients with antiphospholipid syndrome (APS) have higher levels of circulating anti-NET antibodies than healthy controls, indicating a potential biomarker.

Filed under:ConditionsOther Rheumatic ConditionsResearch Rheum Tagged with:anti-NET antibodiesAntiphospholipid Antibody Syndrome (APS)APScellsNETosisneutrophil extracellular trapsRheumMadness

ACR Insurance Subcommittee Chair Encourages Member Engagement

Carina Stanton  |  January 20, 2022

Rheumatology practices have a voice in payer advocacy through the Insurance Subcommittee of the ACR’s Committee on Rheumatologic Care.

Filed under:InsuranceLegislation & AdvocacyProfiles Tagged with:ACR Insurance Subcommittee (ISC)AdvocacyCommittee on Rheumatologic Care (CORC)insurance advocacyRebecca Shepherd

Electronic Consultations Could Improve Access to Rheumatologic Care

Samantha C. Shapiro, MD  |  January 20, 2022

Patients shouldn’t need to exercise patience when it comes to getting needed rheumatologic care. E-consults are an evolving telehealth modality with the potential to improve access to rheumatologic care in a cost-effective and efficient manner.

Filed under:Practice SupportWorkforce Tagged with:Access to careReferraltelehealthWorkforceWorkforce Study

The Power of Advocacy

Blair Solow, MD  |  January 10, 2022

In 1916, a handful of conservation advocates successfully lobbied Congress to create the National Park Service, which now protects more than 85 million acres of U.S. land. Dedicated rheumatology advocacy has lasting effects, too, as evidenced by several policy wins in 2021 and efforts underway for 2022.

Filed under:Legislation & Advocacy Tagged with:ACR advocacyAdvocacyBuild Back Better ActLegislationMedicare reimbursement ratePediatric Subspecialty Loan Forgivenesspharmacy benefit managers (PBMs)Research Fundingstate legislationstep therapy legislationtelehealthWorkforce

Supporting Rheumatologic Care for Pediatric Patients

Mary Beth Nierengarten  |  January 10, 2022

As chair of the Pediatric Rheumatology Special Committee, Colleen Correll, MD, MPH, is supporting efforts to increase the pediatric rheumatology workforce as a whole and pediatric rheumatology representation in the ACR.

Filed under:Profiles Tagged with:ACR’s Pediatric Rheumatology Special CommitteeColleen CorrellWorkforce

Late 2021’s Awards, Appointments & Announcements in Rheumatology

Gretchen Henkel  |  January 10, 2022

Joan Von Feldt, MD, Named a PANLAR Master On Aug. 12, 2021, the Pan American League of Associations for Rheumatology (PANLAR) named Joan Von Feldt, MD, MSEd, FACR, FACP, MACR, a PANLAR Master. Dr. Von Feldt, a past president of the ACR (2015–16) and an emeritus professor of medicine at the Perelman School of Medicine,…

Filed under:Awards Tagged with:Dr. Joan Von FeldtDr. Lisa A. Zickuhr

Harder to Breathe: The Infrastructure Behind Medical Oxygen

Philip Seo, MD, MHS  |  January 10, 2022

Last year, in Texas, they had no room to breathe. Texas has 301 designated trauma centers equipped to provide intensive care, 200 of which can care for at least four critically ill patients. In August 2021, 75 of these hospitals reported having no available beds in their intensive care units. Zero. This was due, in…

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:infrastructure

  • « Previous Page
  • 1
  • …
  • 86
  • 87
  • 88
  • 89
  • 90
  • …
  • 329
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences